http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20040549-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2004-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e726425054bb468a7906fa21973d08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c995743a7658d24e61d43c4e736aa877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9405ee7cb9d4c5557f4997c2e90c618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5a05ef2496906895d5ce2bd256faf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb05dee501b23e8759e434c518ea6fef
publicationDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20040549-B1
titleOfInvention 3-HETEROaryl-3,5-DIHYDRO-4-OXO-4H-pyridazino [4,5-B] INDOL-1-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND USE IN THERAPY
abstract <IMAGE NAME = "20040549_01" TYPE = "jpg" CENTER = TRUE /> The present invention relates to compounds of general formula (I), wherein: X represents a hydrogen or halogen atom; R <SUB> 1 </SUB> represents a hydrogen atom or an (C <SUB> 1 </SUB> -C <SUB> 4 </SUB>) alkyl group; R <SUB> 2 </SUB> and R <SUB> 3 </SUB> represent, independently of one another, a hydrogen atom or (C <SUB> 1 </SUB> -C <SUB> 4 </SUB> ) an alkyl group, or R <SUB> 2 </SUB> and R <SUB> 3 </SUB> form, together with the nitrogen atom to which they are attached, a pyrrolidinyl, piperidinyl, mophrolinyl or 4-alkylpiperazinyl group; and Het represents a heteroaromatic group of the type pyridinyl, 1-oxidopyridinyl, quinolinyl, isoquinolinyl, pyrimidinyl, pyrazinyl, pyridazinyl, wherein the heteroaromatic group may contain one or more halogen atoms and / or one or more (C <SUB> 1 </SUB> - C <SUB> 4 </SUB>) alkyl or (C <SUB> 1 </SUB> -C <SUB> 4 </SUB>) alkoxyl groups; in the form of bases, acid addition salts, solvates or hydrates. The invention also relates to pharmaceutical compositions containing them, to processes for their preparation, as well as to the synthesis of intermediates.
priorityDate 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9815552-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0208229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0044751-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13841310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420236948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456414897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288

Total number of triples: 71.